| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |